Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1608Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | BL0120007 | - |
| dc.date.accessioned | 2024-05-06T07:07:41Z | - |
| dc.date.available | 2024-05-06T07:07:41Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1608 | - |
| dc.description.abstract | Introduction: Osteoporosis is characterized by low bone mass, microarchitectural disruption, and increased skeletal fragility, resulting in decreased bone strength and increased risk of fracture. Zoledronic acid is a bisphosphonate which can be given once in a year IV, has better patient compliance and good clinical efficacy compared to other oral bisphosphonates. The present study aimed to evaluate the effect of Zoledronic acid in patients with low back pain due to osteoporosis | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.subject | Bone Mineral Density, Zoledronic Acid, Bisphosphates, Osteoporosis, Mineralization | en_US |
| dc.title | Study Of Effect Of Zoledronic Acid On Back Pain In Patients With Osteoporosis | en_US |
| dc.type | Dissertations | en_US |
| Appears in Collections: | Orthopaedics MS | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| BL0120007.pdf | 4.27 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.